Home » Medical » The Wait Is Over — FDA Approves Device for Long-Standing Persistent AfibMedicalThe Wait Is Over — FDA Approves Device for Long-Standing Persistent Afib Manny Johnson April 30, 2021 1 Views AtriCure’s EPi-Sense enables the only approved hybrid therapy for the most severe atrial fibrillation (Afib) patients. The device is supported by strong 18-month clinical trial data.
